Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War) Other Current Liabilities

Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War) (PBAXU) currently reports a other current liabilities of $16M as of June 2026. That compares with $470K in the prior-year period — up 3206.6% year over year. Use the charts on this page to explore Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War)'s other current liabilities history and peer comparisons.

Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War)'s other current liabilities increased from $470K to $16M — a 3206.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War) reported $16M in other current liabilities as of June 2026. That compares with $470K in the prior-year period — up 3206.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War), and consider following PBAXU for alerts when major investors trade the stock.